Feedback / Questions
Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL
https://www.pharmiweb.com/press-release/2023-06-06/bial-announces-positive-results-from-phase-3-study-in-early-levodopa-treated-parkinson-s-disease-patients-without-motor-complications
Jun 5, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next